Citation

Buchanan D, Tourigny-Rivard MF, Cappeliez P, Frank C, Janikowski P, Spanjevic L, Malach FM, Mokry J, Flint A, Herrmann N. Canadian Journal of Geriatrics 2006; 9(Suppl 2): S52-S58.

Copyright

(Copyright © 2006)

DOI

unavailable

PMID

unavailable

Abstract

The aim of this guideline is to improve the assessment, treatment, and management of depression in older adults and to promote mental health through the provision of evidence-based recommendations. The initial sections address issues related to screening and assessing for depression and outline the various treatment approaches (i.e., psychotherapy and pharmacologic interventions) recommended, depending on the type of depression and degree of severity. The treatment modalities for depression are then presented in more detail, followed by recommendations for monitoring treatment. The final sections address issues related to education, special populations, and systems of care for depression in older adults.

Language: en

Keywords

human; Depression; suicide; dementia; quality of life; Treatment; bipolar disorder; psychotherapy; depression; psychosis; major depression; lithium; disease severity; patient education; risk factor; review; disease classification; antidepressant agent; mental health care; neuroleptic agent; dysthymia; geriatric care; amfebutamone; citalopram; clinical feature; fluoxetine; mirtazapine; moclobemide; serotonin uptake inhibitor; sertraline; tricyclic antidepressant agent; venlafaxine; patient monitoring; behavior therapy; cognitive therapy; patient referral; practice guideline; electroconvulsive therapy; drug blood level; Guidelines; psychosocial care; long term care; diagnostic test; prophylaxis; screening test; side effect; escitalopram; evidence based medicine; agitation; drug half life; health care system; anticholinergic effect; mood stabilizer; unspecified side effect; drug dose reduction; drug dose titration; clinical assessment; treatment duration; Elderly assessment